Literature DB >> 20692773

[Robotic gynecologic surgery: state of the art. Review of the literature].

C Zacharopoulou1, N Sananes, E Baulon, O Garbin, A Wattiez.   

Abstract

Tele-operating robots, that have been developing for 10 years, are a revolution in the field of minimally invasive gynaecology. Indeed, by restoring three-dimensional view and the surgeon's hand freedom, the robot diminishes the technical difficulties of laparoscopy. The robot brings the surgeon back to open-air movements while preserving the minimally invasive aspect of the procedure and should, therefore, allow an easier transition for laparotomic surgeons to minimally invasive techniques. However, some inconvenients remain: the robot's size, its time-consuming installation, the lack of force feedback and the cost of robotic surgery. To this day, the robot was used in gynaecology for tubal reversal, myomectomies, hysterectomies, promontofixations and the treatment of gynaecological cancers, but the benefits compared to laparoscopic techniques have not yet been demonstrated and will require large scale prospective studies. These benefits will also have to be weighed up to the cost and organizational constraints.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20692773     DOI: 10.1016/j.jgyn.2010.06.008

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  2 in total

1.  Robotic harvest of the rectus abdominis muscle: principles and clinical applications.

Authors:  Amir E Ibrahim; Karim A Sarhane; John C Pederson; Jesse C Selber
Journal:  Semin Plast Surg       Date:  2014-02       Impact factor: 2.314

2.  Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study.

Authors:  Antonio Toesca; Nickolas Peradze; Andrea Manconi; Viviana Galimberti; Mattia Intra; Marco Colleoni; Bernardo Bonanni; Giuseppe Curigliano; Mario Rietjens; Giuseppe Viale; Virgilio Sacchini; Paolo Veronesi
Journal:  Breast       Date:  2016-11-02       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.